Literature DB >> 3863752

Prostaglandins as hormones.

N Shimizu, T Nakamura.   

Abstract

In recent years, the concept of a hormone has been greatly changed, and the term 'cybernin' is used to describe a substance which possesses not only endocrine activity but also has autocrine and paracrine effects. The cytoprotective effects of prostaglandins are reviewed with respect to the relationship between prostaglandins and cyclic AMP, and to the effects of prostaglandins on ion transport. Prostaglandins are produced by cell membranes of many tissues and are found in the vasculature. However, the metabolic degradation of prostaglandins is rapid and their significance as circulatory hormones has not been clarified. Yet it is clear that prostaglandins have important physiological activity and it is possible that the effects of prostaglandins are mediated by paracrine or autocrine mechanisms. In order to classify prostaglandins as hormones, it is necessary to clarify their biological activities, to identify a specific and saturable receptor, and to determine a second messenger. This paper discusses the extent to which prostaglandins conform to our present concept of hormones. The existence of a prostaglandin receptor and the role of adenylate cyclase have been confirmed using cultured cell clones. The following observations have been made. (i) For a series of compounds, potency in competing for (3H)PGE1 binding sites correlated with their ability to stimulate adenylate cyclase activity. (ii) There was a relationship between rates of binding and change in enzyme activity. (iii) The presence or absence of PGE1-sensitive adenylate cyclase corresponded to (3H)PGE1 binding capacity. The presence of a prostaglandin receptor has been identified in rat liver, bovine thyroid, bovine corpus luteum, frog erythrocyte, hamster adipocyte, and human adipocyte.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3863752     DOI: 10.1007/bf01309394

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  Regulation of prostaglandin receptors by prostaglandins and guanine nucleotides in frog erythrocytes.

Authors:  R J Lefkowitz; D Mullikin; C L Wood; T B Gore; C Mukherjee
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

2.  Binding of (3H)prostaglandin E1 to putative receptors linked to adenylate cyclase of cultured cell clones.

Authors:  L L Brunton; R A Wiklund; P M Van Arsdale; A G Gilman
Journal:  J Biol Chem       Date:  1976-05-25       Impact factor: 5.157

3.  Characterization of prostaglandin receptors in the bovine corpus luteum cell membranes.

Authors:  C V Rao
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

4.  Effects of prostaglandins on adenosine 3',5'-monophosphate levels in fat and other tissues.

Authors:  R W Butcher; C E Baird
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

5.  Binding of prostaglandin E1 to beef thyroid membranes.

Authors:  W V Moore; J Wolff
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

6.  Prostaglandin E2 receptor binding and action in human fat cells.

Authors:  B Richelsen; E F Eriksen; H Beck-Nielsen; O Pedersen
Journal:  J Clin Endocrinol Metab       Date:  1984-07       Impact factor: 5.958

7.  Guanine nucleotides and monovalent cations increase agonist affinity of prostaglandin E2 receptors in hamster adipocytes.

Authors:  R Grandt; K Aktories; K H Jakobs
Journal:  Mol Pharmacol       Date:  1982-09       Impact factor: 4.436

8.  Antagonism of prostaglandin E2 by 1-acetyl-2-(8-chloro-10,11-dihydrodibenz (b,f) (1,4) oxazepine-10-carbonyl) hydrazine (SC-19220).

Authors:  J H Sanner
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-07

9.  Evidence for a PGE-receptor in the rat kidney.

Authors:  H G Oien; E M Babiarz; D D Soderma; E A Ham; F A Kuehl
Journal:  Prostaglandins       Date:  1979-04

10.  Gastrin and somatostatin secretion by perfused rat stomach: functional linkage of antral peptides.

Authors:  B Saffouri; G C Weir; K N Bitar; G M Makhlouf
Journal:  Am J Physiol       Date:  1980-06
  10 in total
  3 in total

Review 1.  Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.

Authors:  J P Monk; S P Clissold
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

2.  Prostaglandin E2 Enhances Gap Junctional Intercellular Communication in Clonal Epithelial Cells.

Authors:  Alejandro Ogazon Del Toro; Lidia Jimenez; Mauricio Serrano Rubi; Aida Castillo; Lorena Hinojosa; Jacqueline Martinez Rendon; Marcelino Cereijido; Arturo Ponce
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

3.  Contaminants of Emerging Concern in Bats from the Northeastern United States.

Authors:  Anne L Secord; Kathleen A Patnode; Charles Carter; Eric Redman; Daniel J Gefell; Andrew R Major; Daniel W Sparks
Journal:  Arch Environ Contam Toxicol       Date:  2015-08-06       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.